Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-02-08Clinical Trial Update: The STAGE Study for Bipolar Disorder [NA]
This is a clinical trial update for the STAGE Study investigating Bipolar Disorder, with the trial status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2016-02-05Clinical Trial Update: Effect of African Drumming in Mood Disorders
This clinical trial update reports that a study evaluating African drumming as an intervention for mood disorders has completed. The sponsor…
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Pilot Study of Interpersonal and Social Rhythm Therapy for Subthreshold Bipolar [NA]
A pilot trial evaluating interpersonal and social rhythm therapy for subthreshold bipolar symptoms in bipolar disorder NOS has completed. Th…
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Reducing Internalized Stigma in People With Serious Mental Illness [Phase 2]
Phase 2 trial update evaluating an intervention to reduce internalized stigma in people with serious mental illness, including schizophrenia…
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Quetiapine for Bipolar Disorder and Alcohol Dependence [Phase 4]
Phase 4 trial update indicating that a study of quetiapine for bipolar disorder with alcohol dependence has completed and its results have b…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-01-27FDA Approved: OLANZAPINE — Original Application (Upsher-Smith Laboratories, LLC)
Approval of a generic olanzapine product under an Original Application (ANDA) by Upsher-Smith Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2016-01-22Clinical Trial Update: Life Goals Collaborative Care to Improve Health Outcomes in Mental Disorders [NA]
The Life Goals Collaborative Care trial evaluating health outcomes in mental disorders has completed, with results posted on Jan 22, 2016.
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Determination of Absorption and Elimination of Lamotrigine-XR [Phase 1, Phase 2]
This update reports a Phase 1/2 pharmacokinetic assessment of Lamotrigine-XR to determine its absorption and elimination. Results have been …
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: Pediatric Bipolar Disorder Study at UCLA
A pediatric bipolar disorder study conducted at the University of California, Los Angeles has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Pilot Study of Adjunctive Yoga for Bipolar Depression [NA]
Reports the completion of a pilot randomized trial evaluating adjunctive yoga as an add-on therapy for bipolar depression. The document deta…
-
CLINICAL_TRIALS research · 2016-01-12Clinical Trial Update: Implementation of Illness Management and Recovery in Mental Health Services [NA]
A clinical trial evaluating the implementation of Illness Management and Recovery in mental health services has completed, focusing on patie…
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: L-Carnosine for Bipolar I Disorder [NA]
A clinical trial evaluating L-Carnosine for Bipolar I Disorder conducted by the University of Pittsburgh has completed.
-
FDA approval · 2016-01-04FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Dr. Reddy's Laboratories Ltd)
The FDA approved a supplemental application for divalproex sodium submitted by Dr. Reddy's Laboratories Ltd.
-
FDA approval · 2016-01-04FDA Approved: QUETIAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for a generic quetiapine product from Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2016-01-01Clinical Trial Update: Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients [Phase 4]
Phase 4 trial completed evaluating metformin for antipsychotic-induced metabolic syndrome in bipolar disorder patients. The study, sponsored…
-
FDA approval · 2015-12-26FDA Approved: VALPROIC ACID — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for valproic acid from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2015-12-23FDA Approved: LAMOTRIGINE — Supplemental Application (Advagen Pharma Limited)
FDA approved a supplemental application for lamotrigine by Advagen Pharma Limited, documenting the approved generic lamotrigine product unde…
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients [Phase 4]
Phase 4 study investigating the effects of olanzapine on sleep architecture and related cognitive changes in patients with bipolar disorder …
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: Effect of Quetiapine on Sleep Architecture in Bipolar Depression and Major Depressive Disorder
Clinical trial update examining the effect of quetiapine on sleep architecture in bipolar depression and major depressive disorder. The stud…
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study
This observational study describes real-world use of quetiapine extended-release in France for schizophrenia and bipolar disorder, summarizi…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: Open-label Adjunctive Zonisamide for Bipolar Disorder [Phase 4]
This is an open-label Phase 4 trial of adjunctive zonisamide for bipolar disorder that has been terminated.
-
FDA approval · 2015-12-11FDA Approved: LAMOTRIGINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Lamotrigine submitted by Zydus Pharmaceuticals USA Inc., authorizing changes to the product …
-
CLINICAL_TRIALS research · 2015-12-10Clinical Trial Update: Study of the Genetic and Environmental Factors of Vulnerability in Bipolar Disorders [NA]
This entry describes an ongoing clinical study investigating the genetic and environmental factors contributing to vulnerability in bipolar …
-
CLINICAL_TRIALS research · 2015-12-07Clinical Trial Update: Functional and Neurochemical Brain Changes in First-episode Bipolar Mania
A completed clinical trial investigating functional and neurochemical brain changes in patients with first-episode bipolar mania.
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384) [Phase 3]
Phase 3 trial evaluating the efficacy and safety of asenapine in preventing recurrence of mood episodes in Bipolar I Disorder has completed.